Abstract
Anti-apoptotic protein BCL-XL plays a key role in tumorigenesis and cancer chemotherapy resistance, rendering it an attractive target for cancer treatment. However, BCL-XL inhibitors such as ABT-263 cannot be safely used in the clinic because platelets solely depend on BCL-XL to maintain their viability. To reduce the on-target platelet toxicity associated with the inhibition of BCL-XL, we designed and synthesized PROTAC BCL-XL degraders that recruit CRBN or VHL E3 ligase because both of these enzymes are poorly expressed in human platelets compared to various cancer cell lines. We confirmed that platelet-toxic BCL-XL/2 dual inhibitor ABT-263 can be converted into platelet-sparing CRBN/VHL-based BCL-XL specific degraders. A number of BCL-XL degraders are more potent in killing cancer cells than their parent compound ABT-263. Specifically, XZ739, a CRBN-dependent BCL-XL degrader, is 20-fold more potent than ABT-263 against MOLT-4 T-ALL cells and has >100-fold selectivity for MOLT-4 cells over human platelets. Our findings further demonstrated the utility of PROTAC technology to achieve tissue selectivity through recruiting differentially expressed E3 ligases.
Citations
Jun 2, 2020·Oncogene·Sajid KhanDaohong Zhou
Jul 29, 2020·Journal of Hematology & Oncology·Yonghan HeDaohong Zhou
Dec 19, 2020·SLAS Discovery·Radosław P Nowak, Lyn H Jones
Oct 25, 2020·European Journal of Medicinal Chemistry·Xueyang JiangHaopeng Sun
Nov 9, 2020·European Journal of Medicinal Chemistry·Shenxin ZengZhengrong Shen
Jan 17, 2021·European Journal of Medicinal Chemistry·Guoyi YanRui Li
Feb 16, 2021·Frontiers in Molecular Biosciences·Diana L BonillaEdmond Chua
Feb 18, 2021·Journal of Medicinal Chemistry·Peter S DragovichXiaoyu Zhu
Feb 23, 2021·SLAS Discovery·Andrew X ZhangAndrea M Zuhl
May 5, 2021·Cell Chemical Biology·Aimo Kannt, Ivan Đikić
May 29, 2021·Scientific Reports·Stephanie DiazXing Liu
Jul 3, 2021·Cancers·Gabriel LaPlante, Wei Zhang
Jan 1, 2020·Exploration of Targeted Anti-tumor Therapy·Peiyi ZhangGuangrong Zheng
Aug 6, 2021·Frontiers in Cell and Developmental Biology·Jing LiuWenyi Wei
Aug 20, 2021·European Journal of Medicinal Chemistry·Chao WangDongming Xing
Aug 17, 2020·Cell Chemical Biology·Dhanusha A Nalawansha, Craig M Crews
Aug 23, 2021·Drug Discovery Today·Scott J HughesIan Churcher
Jul 23, 2020·ACS Chemical Biology·Chun-Wa ChungAndrew B Benowitz
Sep 14, 2021·Biochemical Society Transactions·Erinna F Lee, W Douglas Fairlie
Sep 18, 2021·Journal of Medicinal Chemistry·Pratik PalGuangrong Zheng
Sep 24, 2021·Pflügers Archiv : European journal of physiology·Hyoung Kyu KimJin Han